SCHEMBL570228

SCHEMBL570228

O=[C]CC(=O)C[C]=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10939811 0.85 GABRR1 (0.30)
SCHEMBL1178565 0.79
SCHEMBL3849153 0.79
SCHEMBL6003642 0.79
SCHEMBL11232307 0.79
SCHEMBL570999 0.77
SCHEMBL11545862 0.77
SCHEMBL217720 0.77
SCHEMBL9949606 0.75
SCHEMBL1182092 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2566969-A2 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF BUTADIENE Genomatica, Inc. (US) 2013-03-13 EP claimed
WO-2011140171-A2 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF BUTADIENE GENOMATICA, INC. (US) 2011-11-10 WO claimed
CN-109422759-B Micromolecule modified taxane water-soluble prodrug and medicinal application thereof 复旦大学 2021-05-04 CN disclosed
EP-3488000-A1 METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION INVISTA Textiles (U.K.) Limited (GB) 2019-05-29 EP disclosed
WO-2018022633-A1 METHODS AND MATERIALS FOR BIOSYNTHESIZING MULTIFUNCTIONAL, MULTIVARIATE MOLECULES VIA CARBON CHAIN MODIFICATION INVISTA TEXTILES (U.K.) LIMITED (GB) 2018-02-01 WO disclosed
EP-3011018-A2 COMPOSITIONS AND METHODS FOR CLOSTRIDIAL TRANSFORMATION Danisco US Inc. (US) 2016-04-27 EP disclosed
EP-2971021-A2 MICROORGANISMS AND METHODS FOR PRODUCING BUTADIENE AND RELATED COMPOUNDS BY FORMATE ASSIMILATION Genomatica, Inc. (US) 2016-01-20 EP disclosed
WO-2015100168-A1 COMPOSITION AND METHODS FOR CONTROL OF INDUSTRIAL SCALE PRODUCTION OF BIO-PRODUCTS DANISCO US INC. (US) 2015-07-02 WO disclosed
WO-2014205355-A2 COMPOSITIONS AND METHODS FOR CLOSTRIDIAL TRANSFORMATION DANISCO US INC. (US) 2014-12-24 WO disclosed
US-20140357838-A1 N-Terminally Modified Insulin Derivatives NOVO NORDISK A/S (DK) 2014-12-04 US disclosed
EP-2794648-A1 N-TERMINALLY MODIFIED INSULIN DERIVATIVES Novo Nordisk A/S (DK) 2014-10-29 EP disclosed
WO-2013093009-A1 N -TERMINALLY MODIFIED INSULIN DERIVATIVES NOVO NORDISK A/S (DK) 2013-06-27 WO disclosed
EP-2566969-A2 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF BUTADIENE Genomatica, Inc. (US) 2013-03-13 EP disclosed
WO-2012177710-A1 MICROORGANISMS FOR PRODUCING BUTADIENE AND METHODS RELATED THERETO GENOMATICA, INC. (US) 2012-12-27 WO disclosed
WO-2012106516-A1 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF BUTADIENE GENOMATICA, INC. (US) 2012-08-09 WO disclosed
WO-2012049307-A2 NOVEL N-TERMINALLY MODIFIED INSULIN DERIVATIVES NOVO NORDISK A/S (DK) 2012-04-19 WO disclosed
WO-2012018624-A2 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF AROMATICS, 2,4-PENTADIENOATE AND 1,3-BUTADIENE GENOMATICA, INC. (US) 2012-02-09 WO disclosed
WO-2011140171-A2 MICROORGANISMS AND METHODS FOR THE BIOSYNTHESIS OF BUTADIENE GENOMATICA, INC. (US) 2011-11-10 WO disclosed
US-20060264529-A1 ACTIVE ENERGY RAY CURABLE COMPOSITION KONICA MINOLTA HOLDINGS, INC. (JP) 2006-11-23 US disclosed
US-20040167315-A1 Active energy ray curable composition KONICA MINOLTA HOLDINGS, INC. (JP) 2004-08-26 US disclosed